On-Demand | Evaluation and Management of Congenital Adrenal Hyperplasia

Availability

On-Demand

Cost

Member: $0.00

Non-Member: $45.00

In-Training Member: $0.00

Resident Member: $0.00

Resident Non-Member: $45.00

Credit Offered

1 ABIM-MOC Point

1 Participation Credit

Course Description
Target Audience
Learning Objectives
Accreditation Statement
Faculty and Disclosures
Recommended

This course is the recording of the live webinar that took place on Thursday, November 20, 2024.

This webinar presentation will provide a review of evaluation and management of congenital adrenal hyperplasia (CAH), a group of autosomal recessive disorders characterized by enzyme deficiencies affecting steroid synthesis. Participants will explore both classic and non-classic CAH, with a focus on holistic management of adult patients. Classic CAH presents early in life and requires complex management of glucocorticoid and mineralocorticoid replacement and androgen excess, while non-classic CAH often emerges in adulthood with milder symptoms. Key management goals include balancing hormone replacement, supporting growth and development, and addressing metabolic and psychosocial aspects of care. The webinar will also cover recent advances, including modified-release glucocorticoid replacement therapies and emerging treatments like Crinecerfont, Tildacerfont, other newer forms of treatment including gene therapy, which aim to improve patient outcomes and quality of life. Relevant case studies will be presented.

Physicians-in-Practice, Fellows, Residents, Nurse/Nurse Practitioner, Physician Assistant

With completion of this webinar a learner should be able to:

1. Identify signs and symptoms of patients with CAH
2. Start on appropriate therapy and titrate the treatment
3. Monitor for metabolic complications of overtreatment
4. Effectively manage transition from pediatric to adult care
5. Empower the patient with management of their own condition with education about sick day rules and treatment during illness and emergency

The Endocrine Society is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. Endocrine Society has achieved Accreditation with Commendation.

AMA PRA Category 1 Credit
The Endocrine Society designates each activity in this course for a maximum of 1 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. While offering CME credits noted above, this program is not intended to provide extensive training or certification in the field.

Please note that while other accrediting bodies accept AMA PRA Category 1 credit, we can only award and report this credit for MDs/DOs. For those outside of this accreditation, please complete the participation evaluation and use that certificate as proof of attendance to submit to your accrediting body.

Maintenance of Certification (MOC)
Successful completion of each CME activity in this course, which includes participation in the evaluation component, enables the participant to earn up to 1 points in the American Board of Internal Medicine (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

For questions about content or obtaining CME credit, please contact the Endocrine Society at info@endocrine.org

Presenter 1:

Shaishav S. Dhage, MD ,DNB, MRCP, MRCP
Consultant Endocrinologist
Christie Hospital, Manchester, UK

Presenter 2:
Shawg Ganawa, MD
Manchester University NHS Foundation Trust

As a provider of CME accredited by the Accreditation Council for Continuing Medical Education, the Endocrine Society has a policy of ensuring that the content and quality of this educational activity are balanced, independent, objective, and scientifically rigorous. The scientific content of this activity was developed under the supervision of the Endocrine Society’s peer reviewers.

DISCLOSURE POLICY
The faculty, committee members, and staff who are in position to control the content of this activity are required to disclose to the Endocrine Society and to learners any relevant financial relationship(s) of the individual that have occurred within the last 12 months with any commercial interest(s) whose products or services are related to the content. Financial relationships are defined by remuneration in any amount from the commercial interest(s) in the form of grants; research support; consulting fees; salary; ownership interest (e.g., stocks, stock options, or ownership interest excluding diversified mutual funds); honoraria or other payments for participation in speakers' bureaus, advisory boards, or boards of directors; or other financial benefits. The intent of this disclosure is not to prevent planners with relevant financial relationships from planning or delivery of content, but rather to provide learners with information that allows them to make their own judgments of whether these financial relationships may have influenced the educational activity with regard to exposition or conclusion.

The Endocrine Society staff involved in the development of this CME activity reported no relevant financial relationships.

The Endocrine Society staff have reviewed all disclosures and resolved or managed all relevant identified conflicts of interest, as applicable.


EndoCareers \| Contact Us \| Privacy Policy \| Terms of Use	CONNECT WITH US
© 2021 Copyright Endocrine Society. All rights reserved.	2055 L Street NW, Suite 600 \| Washington, DC 20036 202.971.3636 \| 888.363.6274